2. Academic Validation
  3. Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?

Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?

  • Bioorg Med Chem Lett. 2003 Aug 4;13(15):2459-63. doi: 10.1016/s0960-894x(03)00496-7.
Carole Anastasi 1,  Patrick Vlieghe,  Olivier Hantz,  Olivier Schorr,  Christophe Pannecouque,  Myriam Witvrouw,  Erik De Clercq,  Pascal Clayette,  Nathalie Dereuddre-Bosquet,  Dominique Dormont,  Françoise Gondois-Rey,  Ivan Hirsch,  Jean-Louis Kraus
Affiliations

Affiliation

  • 1 Laboratoire de Chimie Biomoléculaire, INSERM U-382, IBDM, Université Méditerranée, Parc Scientifique de Luminy, 163 avenue de Luminy, case 901, 13288 Marseille Cedex 9, France.
PMID: 12852943 DOI: 10.1016/s0960-894x(03)00496-7
Abstract

In contrast to 5'-O-carbonate 3TC derivatives (23, 24), which are clearly 3TC prodrugs, the corresponding 3TC carbamates (15-21 and 25), found to be very stable compounds with respect to enzymatic hydrolysis (cellular lysates and culture cell media) and still active on both HIV-1 and HBV infected cells, may not be 3TC prodrugs. The Antiviral properties as well as the mechanism of action of 3TC analogues have been studied and evaluated.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z